Webinar Event 1:Aired November 14th, 2018 at 10 AM PST

Identification and Validation of New Targets and Compounds for Inflammatory Diseases

Our CSO, Dr. George Nicola, Director of Bioinformatics, Dr. John Schomberg, and CEO, Dr. Bruce Kovacs, will be hosting an engaging demonstration of our platform technologies. We look forward to having you join us and learn about how to shorten your discovery timelines to reduce the costs of bringing critical medicines to patients that need them.